Comparison between Curis Lifesciences IPO and Vigor Plast IPO.
Curis Lifesciences IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Vigor Plast IPO is a SME Bookbuilding proposed to list at NSE SME.
| Curis Lifesciences IPO | Vigor Plast IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Finaax Capital Advisors Private Limited | Unistone Capital Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | RS Wealth Management Private Limited | Alacrity Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Curis Lifesciences IPO is up to ₹26.14 Cr whereas the issue size of the Vigor Plast IPO is up to ₹23.85 Cr. The final issue price of Curis Lifesciences IPO is ₹128.00 per share and of Vigor Plast IPO is ₹81.00 per share.
| Curis Lifesciences IPO | Vigor Plast IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹120.00 per share | ₹77.00 per share |
| Issue Price (Upper) | ₹128.00 per share | ₹81.00 per share |
| Issue Price (Final) | ₹128.00 per share | ₹81.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1600 shares |
| Fresh Issue Size | 20,42,000 shares | 23,44,000 shares |
| Fresh Issue Size (Amount) | up to ₹26.14 Cr | up to ₹18.99 Cr |
| OFS Issue Size | 0 shares | 6,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹4.86 Cr |
| Issue Size Total | 20,42,000 shares | 29,44,000 shares |
| Issue Size Total (Amount) | up to ₹26.14 Cr | up to ₹23.85 Cr |
Curis Lifesciences IPO opens on Nov 07, 2025, while Vigor Plast IPO opens on Sep 04, 2025. The closing date of Curis Lifesciences IPO and Vigor Plast IPO is Nov 11, 2025, and Sep 09, 2025, respectively.
| Curis Lifesciences IPO | Vigor Plast IPO | |
|---|---|---|
| Anchor Bid Date | Nov 06, 2025 | Sep 03, 2025 |
| Issue Open | Nov 07, 2025 | Sep 04, 2025 |
| Issue Close | Nov 11, 2025 | Sep 09, 2025 |
| Basis Of Allotment (Tentative) | Nov 12, 2025 | Sep 10, 2025 |
| Initiation of Refunds (Tentative) | Nov 13, 2025 | Sep 11, 2025 |
| Credit of Share (Tentative) | Nov 13, 2025 | Sep 11, 2025 |
| Listing date (Tentative) | Nov 14, 2025 | Sep 12, 2025 |
| Anchor Lockin End date 1 | Dec 11, 2025 | Oct 09, 2025 |
| Anchor Lockin End date 2 | Feb 09, 2026 | Dec 08, 2025 |
Curis Lifesciences IPO P/E ratio is 12.44, as compared to Vigor Plast IPO P/E ratio of 12.35.
| Curis Lifesciences IPO | Vigor Plast IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Curis Lifesciences Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 25% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Vigor Plast India Ltd.'s revenue increased by 8% and profit after tax (PAT) rose by 76% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.68 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.03 | 70.05 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.44 | 12.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹103.48 Cr. | ₹83.85 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 55.25 | 59.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 27.83 | 28.24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.96 | 1.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.29 | ₹6.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 37.62 | 59.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Curis Lifesciences IPO Retail Individual Investors (RII) are offered 7,16,000 shares while in Vigor Plast IPO retail investors are offered 7,16,000 shares. Qualified Institutional Buyers (QIB) are offered 4,08,000 shares in Curis Lifesciences IPO and 5,90,400 shares in Vigor Plast IPO.
| Curis Lifesciences IPO | Vigor Plast IPO | |
|---|---|---|
| Anchor Investor Reservation | 6,09,000 shares | 8,73,600 shares |
| Market Maker Reservation | 1,08,000 shares | 1,55,200 shares |
| QIB | 4,08,000 shares | 5,90,400 shares |
| NII | 3,09,000 shares | 4,46,400 shares |
| RII | 7,16,000 shares | 10,33,600 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 20,42,000 shares | 29,44,000 shares |
Curis Lifesciences IPO subscribed 74.39x in total, whereas Vigor Plast IPO subscribed 3.88x.
| Curis Lifesciences IPO | Vigor Plast IPO | |
|---|---|---|
| QIB (times) | 96.17x | 3.94x |
| NII (times) | 115.46x | 7.03x |
| Big NII (times) | 142.74x | 9.00x |
| Small NII (times) | 60.38x | 3.09x |
| RII (times) | 44.28x | 2.49x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 74.39x | 3.88x |
